Results 1 to 10 of about 114,729 (340)

Methylprednisolone Treatment in Brain Death-Induced Lung Inflammation–A Dose Comparative Study in Rats [PDF]

open access: yesFrontiers in Pharmacology, 2021
Background: The process of brain death (BD) leads to a pro-inflammatory state of the donor lung, which deteriorates its quality. In an attempt to preserve lung quality, methylprednisolone is widely recommended in donor lung management.
Judith E. Van Zanden   +8 more
doaj   +3 more sources

Effects of methylprednisolone on exercise-induced increases of plasma levels of polymorphonuclear elastase and myeloperoxidase in man. Preliminary results [PDF]

open access: gold, 1993
The aim of the present study was to verify whether a single oral dose of methylprednisolone could modulate the exercise-induced release of polymorphonuclear neutrophil (PMN) elastase and myeloperoxidase. Four healthy, male subjects were submitted to a 20
Camus, G.   +5 more
core   +4 more sources

Acyclovir with Steroid and Steroid Alone in the Treatment of Idiopathic Facial Nerve Palsy: A Randomised Double-blinded Clinical Study from a Tertiary Care Centre, Chennai, India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introdutcion: Idiopathic palsy of facial nerve is an acute disease which causes lower motor neuron palsy characterised by facial asymmetry leads to psychological effects and limits one’s social life.
SR Kartrthika   +3 more
doaj   +1 more source

Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia

open access: yesCritical Care Explorations, 2021
OBJECTIVES:. To determine methylprednisolone’s dose, duration, and administration from onset of symptoms and association with 60 days in hospital survival of coronavirus disease 2019 pneumonia. DESIGN:. Cohort study. SETTING:.
Ronaldo C. Go, MD   +20 more
doaj   +1 more source

Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia

open access: yesBMC Pulmonary Medicine, 2022
Background Mortality in severe COVID-19 pneumonia is associated with thrombo-inflammation. Corticosteroids are given to attenuate the inflammation, but they are associated with thrombosis.
Ronaldo C. Go   +6 more
doaj   +1 more source

Methylprednisolone in Pediatric Cardiac Surgery: Is There Enough Evidence?

open access: yesFrontiers in Cardiovascular Medicine, 2021
Corticosteroids have been used to decrease the inflammatory response to cardiac surgery and cardiopulmonary bypass in children for decades. Sparse information is present concerning the pharmacokinetics and pharmacodynamics of corticosteroids in the ...
Annewil van Saet   +5 more
doaj   +1 more source

Effects of Methylprednisolone on Myocardial Function and Microcirculation in Post-resuscitation: A Rat Model

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundPrevious studies have demonstrated that inflammation and impaired microcirculation are key factors in post-resuscitation syndromes. Here, we investigated whether methylprednisolone (MP) could improve myocardial function and microcirculation by ...
Changsheng Wang   +17 more
doaj   +1 more source

Methylprednisolone pulse therapy for critically ill patients with coronavirus disease 2019: A single‐center retrospective observational study

open access: yesAcute Medicine & Surgery, 2022
Aim This study compared the clinical outcomes of critically ill patients with coronavirus disease (COVID‐19) pneumonia treated with high‐dose methylprednisolone and other steroids.
Hiromu Okano   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy